MIRA
INFORM REPORT
|
Report Date : |
22.01.2007 |
IDENTIFICATION
DETAILS
|
Name : |
CHARAK
PHARMA PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Evergreen
Industrial Estate, Dr. E Moses Road, Shakti Mills Lane, Mahalaxmi, Mumbai –
400011 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
08.06.2000 |
|
|
|
|
Com. Reg. No.: |
11-127072 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24230MH2000PTC127072 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMC07892D |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCC4014A |
|
|
|
|
Legal Form : |
Private
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer,
Chemists, Wholesalers and Retailers Druggist, Importer, Exporter and
Manufacturer Makers, Processors of Formulators and Traders and Dealer in
Pharmaceutical Drugs, Bulk Drugs, Medicines, Intermediates, Chemical,
Mixtures, Tablets, Capsules, Injections, Formulations, Biological Centre,
Captive and Therapeutic Preparations, Substances Materials and articles of
all kinds and classes whether Simple, Compound, or otherwise and Materials,
Dressings, Apparatus, and Contrivances of every description and for any
purpose including in particular but without limiting the generality of the
forgoing Ayurvedic, Scientific, Medical, Homeopathic, Unani, Dental, Veterinary,
Agricultural, Horticultural. |
RATING & COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
Maximum Credit Limit : |
USD
725000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular
|
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject
is an old established company having fine track. Charak is a well known brand
Synonymous to Ayurveda. Available
information indicates high financial responsibility of the company. Trade
relations are fair. Financial position is good. Payments are correct and as
per commitments. The
company can be considered good for any normal business dealing at usual trade
terms. It can
be regarded as a promising business partner in a medium to long – run. |
LOCATIONS
|
Registered Office : |
Evergreen
Industrial Estate, Dr. E Moses Road, Shakti Mills Lane, Mahalaxmi, Mumbai –
400011 |
|
Tel. No.: |
91-22-24965256 |
|
Fax No.: |
91-22-24938215 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head
Office : |
Evergreen
Industrial Estate, 2nd Floor Shakti Mills Lane, Dr.E. Moses Road Mahalaxmi -
400011 |
|
E-Mail
: |
|
|
|
|
|
Factory
1 : |
SAMALKHA UNIT
Silvassa Dadra
Nagar Haveli Plot No.371,Sayli - Rakholi Road - 396230 |
|
|
|
|
DISTRIBUTION CENTRE |
Unit Ac-1-6&
12-15, R.C.C. Building Rajlaxmi Commercial Complex Village Kalher,Agra
Road,Kalher Gram Panchayat Bhiwandi,Thane |
|
E-Mail
: |
|
|
|
|
|
Branches
: |
GHAZIABAD 20/3 Ashwathkatte
Road , Kasturba Nagar, Near Old Tolgate , Mysore Road - 560026 |
DIRECTORS
|
Name : |
Mr.
Shroff Kishor Vikram |
|
Designation : |
Whole
Time Director |
|
Address : |
31,
Ocean Crest, 85 B Desai Road, Mumbai – 400036 |
|
Date of Birth/Age : |
07.03.1968 |
|
Date of Appointment : |
08.06.2000 |
|
|
|
|
Name : |
Mr.
Nimish Kishor Shroff |
|
Designation : |
Whole
Time Director |
|
Address : |
31,
Ocean Crest, 85 B Desai Road, Mumbai – 400036 |
|
Date of Birth/Age : |
21.05.1970 |
|
Date of Appointment : |
08.06.2000 |
|
|
|
|
Name : |
Mr.
Pulin Harshad Shroff |
|
Designation : |
Whole
Time Director |
|
Address : |
142,
Silver Arch, Nepeansea Road, Mumbai – 400006 |
|
Date of Birth/Age : |
11.07.1970 |
|
Date of Appointment : |
08.06.2000 |
|
|
|
|
Name : |
Mr.
Ram Hemant Shroff |
|
Designation : |
Whole
Time Director |
|
Address : |
11,
Vallabh Apartments, 87 B Desai Road, Mumbai – 400036 |
|
Date of Birth/Age : |
28.08.1971 |
|
Date of Appointment : |
08.06.2000 |
|
|
|
|
Name : |
Mr.
Raj Hemant Shroff |
|
Designation : |
Whole
Time Director |
|
Address : |
11,
Vallabh Apartments, 87 B Desai Road, Mumbai – 400036 |
|
Date of Birth/Age : |
28.08.1971 |
|
Date of Appointment : |
08.06.2000 |
KEY EXECUTIVES
|
Name
: |
Mr.
Murali Ganapathi Kizhakkenchery |
|
Designation
: |
Secretary |
|
Address
: |
11,
Supralina, 11th Road, Chembur, Mumbai – 400071 |
|
Date
of Birth/Age : |
25.04.1961 |
|
Date
of Appointment : |
15.07.2002 |
MAJOR SHAREHOLDERS
As on 30.09.2005
|
Names
of Shareholders |
No. of Shares |
|
Mr.
Shroff Kishor Vikram |
205177 |
|
Mr.
Nimish Kishor Shroff |
205177 |
|
Mr.
Pullin Harshad Shroff |
205176 |
|
Mr.
Ram Hemant Shroff |
205177 |
|
Mr.
Raj Hemant Shroff |
205176 |
|
Ms.
Amisha Pulin Shroff |
1 |
|
Ms.
Priti Raj Shroff |
1 |
|
M/s.
Charak Healthcare Private Limited |
33334 |
|
|
|
As on 30.09.2006
|
Category
of Shareholders |
Percentage of Holding |
|
Bodies
corporate |
3.15 |
|
Directors
or relatives of directors |
96.85 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer,
Chemists, Wholesalers and Retailers Druggist, Importer, Exporter and
Manufacturer Makers, Processors of Formulators and Traders and Dealer in
Pharmaceutical Drugs, Bulk Drugs, Medicines, Intermediates, Chemical, Mixtures,
Tablets, Capsules, Injections, Formulations, Biological Centre, Captive and
Therapeutic Preparations, Substances Materials and articles of all kinds and
classes whether Simple, Compound, or otherwise and Materials, Dressings,
Apparatus, and Contrivances of every description and for any purpose
including in particular but without limiting the generality of the forgoing
Ayurvedic, Scientific, Medical, Homeopathic, Unani, Dental, Veterinary,
Agricultural, Horticultural. |
|
|
|
|
Product: |
Ayurvedic
Medicines |
PRODUCTION
STATUS
|
Particulars |
Unit |
|
Installed Capacity |
Actual Production |
|
Capsules |
Nos. |
|
15010000 |
40958 |
|
Syrups |
Ltrs. |
|
6000000 |
2656614 |
|
Tablets |
Nos. |
|
|
31973 |
|
Other |
Kgs. |
|
|
4578 |
GENERAL
INFORMATION
|
Distributor |
Abhishekh
Distributors Raipur, India 2535792 / 2229185 Brij Agencies Indore, India 2802434 / 5021929
Himalaya Stores Jammu &
Kashmir, India J J Parikh,
Sarkhej Ahmedabad, India 91-79-26891593/6890705 K S Distributors Jaipur, India M.M. Agencies Varanasi, India Nidhi Traders Ranchi, India 2204932/2314274 OS Enterprises Chandigarh, India 5078504 / 2637871 Prima Medicose Haridwar, India 254727/254803
Sai Venkataramana Hyderabad, India 91-40-27674797 / 98 Shahu Pharma Deal Nagpur, India Amrit Enterprises Lucknow, India 2221537/2284255 Candida
Enterprises Guwahati, India 2630430 / 2542787 Elite Enterprises Patna, India 2228759 / 2224328 Impact
Enterprises Delhi, India 91-11-22053267/22530265 J. Bipinchandra Ahmedabad, India 91-79-5351198 / 5500845 Kurumthottam Kerala, India Milan Enterprises Kolkata, India 91-33-22354915 / 9931 OK Drugs Sangli, India 2377004 / 2372173
/ 2376003 / 2322004 OS Medical Hall Ambala, India Prime Marketing Mumbai, India 91-22-22052521/22017652 Rajeev Agencies Bhubaneshwar,
India 2533197 / 2530519 SAP Agencies Chennai, India |
|||
|
|
|
|||
|
No. of Employees : |
850 |
|||
|
|
|
|||
|
Bankers : |
v
Union
Bank of India, Overseas Branch, Mumbai – 21 v
N.
K. G. S. B. Cooperative Bank Limited, Girgaum Branch |
|||
|
|
|
|||
|
Facilities : |
v
N.
K. G. S. B. Cooperative Bank Limited – Rs. 26.000 Millions – 04.08.2001,
Hypothecation of movable machinery and other assets v
Union
Bank of India, Overseas Branch, Union Bank Bhavan, Ground Floor, 239, Vidhan
Bhavan Marg, Nariman Point, Mumbai – 400021 – Rs. 84.300 Millions –
20.10.2004, Entire plant and machinery both present and future |
|
|
|
|
Banking Relations : |
Good |
|
|
|
|
Auditors : |
Malpani
& Associates Chartered
Accountants |
|
Address: |
307,
Chartered House, 297/299, Dr. Cawasji Hormusji Street, Mumbai - 400002 |
|
Tel. No.: |
91-22-22060236 |
|
|
|
|
Associates/Subsidiaries : |
v
Charak
Pharmaceuticals India Private Limited v
Charak
Animal Health Care Private Limited v
Charak
Health Care Private Limited v
Charak
Censultanex Private Limited v
Charak
Research Foundation v
Charak
Pharmaceutical v
Charak
International v
Charak
Distributors v
Charak
Bhardar v
Vedic
Health Care Private Limited v
Ayurvedg
Agencies v
Dharindhar
Family Trust |
CAPITAL STRUCTURE
Authorised
Capital :
|
No.
of Shares |
Type |
Value |
Amount |
|
60,00,000 |
Equity
Sharers |
Rs. 10/- Each |
Rs. 60.000 Millions |
Issued,
Subscribed & Paid-up Capital :
|
No.
of Shares |
Type |
Value |
Amount |
|
52,96,100 |
Equity
Sharers |
Rs. 10/- Each |
Rs. 52.961 Millions |
FINANCIAL DATA
[all figures are in Rupees
Millions]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
52.961 |
10.592 |
10.592 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
129.168 |
132.878 |
152.618 |
|
|
4] (Accumulated Losses) |
----- |
----- |
---- |
|
|
NETWORTH |
182.129 |
143.470 |
163.210 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
157.631 |
54.809 |
29.248 |
|
|
2] Unsecured Loans |
53.002 |
91.223 |
68.949 |
|
|
TOTAL BORROWING |
210.633 |
146.032 |
98.197 |
|
|
DEFERRED TAX LIABILITIES |
27.303 |
18.485 |
15.111 |
|
|
|
|
|
|
|
|
TOTAL |
420.065 |
307.987 |
276.518 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
299.235 |
161.702 |
168.568 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.117 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.314 |
0.083 |
0.084 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
109.799
|
68.536 |
53.332 |
|
|
Sundry Debtors |
62.003
|
36.661 |
85.389 |
|
|
Cash & Bank Balances |
18.104
|
33.834 |
19.104 |
|
|
Other Current Assets |
34.651
|
18.454 |
0.000 |
|
|
Loans & Advances |
0.000
|
0.000 |
13.777 |
|
Total Current Assets |
224.557
|
157.485 |
171.602 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities & Provisions |
104.041
|
61.835 |
63.853 |
|
|
|
|
|
|
|
Total Current Liabilities |
104.041
|
61.835 |
63.853 |
|
|
Net Current Assets |
120.516
|
95.650 |
107.749 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
PRE-OPERATIVE EXPENSES |
0.000 |
50.552 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
420.065 |
307.987 |
276.518 |
|
PROFIT
& LOSS ACCOUNT
|
PARTICULARS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
Sales Turnover [including other income] |
761.218 |
579.776 |
693.903 |
|
|
|
|
|
|
Profit/(Loss)
Before Tax |
93.509 |
61.904 |
144.599 |
|
Provision
for Taxation |
---- |
---- |
28.486 |
|
Profit/(Loss)
After Tax |
93.509 |
61.904 |
116.113 |
|
|
|
|
|
|
Export
Value |
NA |
NA |
9.332 |
|
|
|
|
|
|
Import
Value |
NA |
NA |
NA |
|
|
|
|
|
|
Total
Expenditure |
667.709 |
517.872 |
564.265 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
PAT / Total Income |
|
12.28
|
10.67 |
16.73 |
|
|
|
|
|
|
|
Net
Profit Margin(PBT/Sales) |
|
12.28
|
10.67 |
20.83 |
|
|
|
|
|
|
|
Return
on Total Assets(PBT/Total Assets} |
|
17.85
|
19.39 |
42.50 |
|
|
|
|
|
|
|
Return
on Investment (ROI)(PBT/Networth) |
|
0.51 |
0.43 |
0.88 |
|
|
|
|
|
|
|
Debt
Equity Ratio(Total Liability/Networth) |
|
1.72
|
1.44 |
0.99 |
|
|
|
|
|
|
|
Current
Ratio(Current Asset/Current Liability) |
|
2.15
|
2.54 |
2.68 |
LOCAL AGENCY
FURTHER INFORMATION
Fixed Assets
v
Land
v
Factory
Building
v
Plant
& Machinery
v
Computer
v
Furniture
& Fixture
v
Vehicles
v
Office
Equipment
As a
part of the company granth plan, the had a brain sterming session in November
2008 a has identified its core strength of has formulated various initiatives
to achieve of turnover of Rs. 2000.000 Millions by year 2009
|
Name of the company |
CHARAK PHARMA PRIVATE LIMITED |
|
1) Date and description of instrument creating the change |
Agreement
of Modification of Charge/ Mortgage modified on 18.07.2006 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs
120.000 Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Agreement
of Charge/ Mortgage created on 13.10.2005 with Rs 80.000 Millions modified on
18.07.2006 with Rs 120.000 Millions |
|
4) Name and Address and description of the person entitled to the charge. |
The
North Kanara G S B Co-operative Bank Limited Laxmi
Sadan, 361, V P Road, Girgaum, Mumbai – 400004, Maharashtra, India |
|
5) Date and brief description of instrument modifying the charge |
18.07.2006 |
|
Name of the company |
CHARAK PHARMA PRIVATE LIMITED |
|
1) Date and description of instrument creating the change |
Agreement
of Satisfaction of Charge/ Mortgage modified on 28.10.2004 and Satisfied on
16.08.2006 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs
48.300 Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Agreement
of Satisfaction of Charge/ Mortgage modified on 28.10.2004 with Rs 48.300
Millions |
|
4) Name and Address and description of the person entitled to the charge. |
Union
Bank of India, Overseas Branch Union
Bank Bhavan, Nariman Point, Mumbai – 400021,
Maharashtra, India |
|
5) Date and brief description of instrument modifying the charge |
Agreement
of Satisfaction of Charge/ Mortgage modified on 28.10.2004 and Satisfied on
16.08.2006 |
|
|
|
|
Name of the company |
CHARAK
PHARMA PRIVATE LIMITED |
|
Presented By |
Union
Bank of India, Overseas Branch, Mumbai |
|
1) Date and description of instrument creating the change |
Agreement of hypothecation dated 20.10.2004 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Foreign currency loan of US Dollars 1832210.39 equivalent to Indian Rs. 84.300 Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation by way of fist charge in favour of the bank of entire plant and machines installed and to be installed in future at the factory including accessories if any parent and future which expression shall include all product goods the borrower which now or hereinafter from time to time |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Interest at the rate of 300% points over libor rate fixed at six monthly interval viz as on date with quarterly rests in US Dollars and or at such other assts as may be prescribed by the bank from time to time Repayment – The borrower shall repay the oust sating under fcl including principal interest an cost in us dollars within 180 days from the date of disbursal of fcl |
|
5) Name and Address and description of the person entitled to the charge. |
Union Bank of India, Overseas Branch, Union Bank Bhavan, Ground Floor,
239, Vidhan Bhavan Marg, Nariman Point, Mumbai – 400021 |
|
6) Date and brief description of instrument modifying the charge |
Not Applicable |
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
Not Applicable |
|
|
|
|
Name of the company |
CHARAK
PHARMA PRIVATE LIMITED |
|
Presented By |
Union
Bank of India, Overseas Branch, Mumbai |
|
1) Date and description of instrument creating the change |
Agreement of hypothecation dated 05.08.2002 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Foreign currency loan of US Dollars 993151.85 equivalent to Indian Rs. 48.299 Millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation by way of fist charge in favour of the bank of entire plant and machines installed and to be installed in future at the factory including accessories if any parent and future which expression shall include all product goods the borrower which now or hereinafter from time to time |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Interest at the rate of 1.50% points over libor rate fixed at six monthly interval viz 3.474 as on date 05.08.2002 with quarterly rests in US Dollars and or at such other assts as may be prescribed by the bank from time to time |
|
5) Name and Address and description of the person entitled to the charge. |
Union Bank of India, Overseas Branch, Union Bank Bhavan, Ground Floor,
239, Vidhan Bhavan Marg, Nariman Point, Mumbai – 400021 |
|
6) Date and brief description of instrument modifying the charge |
Extension memorandum of equitable mortgage on 28.10.2004 |
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
The original charge dated 05.08.2002 for US Dollars 993154.85 equipment to India Rs. 48.299 millions has been modified from time to time as under On 08.08.2002 an equitable mortgage by way of deposited of title deeds was created in respect of company immovable property viz Part I All piece and parcel of the non – agriculture land bearing survey No. 708 admesuring I hectare of village of dadra and nagar haveli. The boundaries of the said land are as under On or towards – Road On or to wards – Border of Rakholi Village and Land of S. No. 371 On or towards the East – Land of Survey No. 374 On or towards the west – border of rakholi village Part II All piece and parcel of the non – agriculture land bearing survey No. 371 admesuring I hectare of village of dadra and nagar haveli. The boundaries of the said land are as under On or towards – Road On or to wards – Border of Rakholi Village and Land of S. No. 369/11 On or towards the East – Land of Survey No. 374 On or towards the west – border of rakholi village Together with building and structures constructed thereon with fixed plant and machinery which may hereafter be erected thereon together US Dollars 993154.85 equipment to India Rs. 48.299 millions Description pf property mortgage earlier Part I All piece and parcel of the non – agriculture land bearing survey No. 708 admesuring I hectare of village of dadra and nagar haveli. The boundaries of the said land are as under On or towards – Road On or to wards – Border of Rakholi Village and Land of S. No. 371 On or towards the East – Land of Survey No. 374 On or towards the west – border of rakholi village Part II All piece and parcel of the non – agriculture land bearing survey No. 371 admesuring I hectare of village of dadra and nagar haveli. The boundaries of the said land are as under On or towards – Road On or to wards – Border of Rakholi Village and Land of S. No. 369/11 On or towards the East – Land of Survey No. 374 On or towards the west – border of rakholi village Together with building and structures constructed thereon with fixed plant and machinery which may hereafter Description pf property mortgage earlier Part I Land measuring bigha biswa bearing akas tatima khasra 139/3 sited in village kathe On or towards the north – Plot No. 186/2, 187, 60/2, 259/4 On or towards the South – Plot No. 139/1 On or towards the East – M/s. Vardhman Group On or towards the West – Plot No. 59/1, 2 Part II Land measuring bigha 10 biswa bearing akas tatima khasra 185/1 sited in village kathe On or towards the north – Plot No. 186/2, 187, 60/2, 259/4 On or towards the South – Plot No. 139/1 On or towards the East – M/s. Vardhman Group On or towards the West – Plot No. 59/1, 2 Part II Land measuring bigha 3 biswa bearing akas tatima khasra 59/3 sited in village kathe On or towards the north – Plot No. 186/2, 187, 60/2, 259/4 On or towards the South – Plot No. 139/1 On or towards the East – M/s. Vardhman Group On or towards the West – Plot No. 59/1, 2 Together with building and structures constructed thereon with fixed plant and machinery which may hereafter Thus the total charge remains at the same leval of US Dollars 993154.85 |
1947 – A year to
remember
Visionary brothers Mr D.N. Shroff and Dr. S.N. Shroff, in the year 1947, were
amongst the pioneers of manufacturing Ayurvedic medicines in India. They drew
inspiration from one of the most authoritative sources on the subject "The Charak
Samhita" compiled by the sage Charaka Circa 1000 BC.
Thus was born Charak Pharma Pvt. Ltd., today one of the largest producers of
high quality Ayurvedic products in India.
Quality and Reproducibility
The two
needs from a medicine are uncompromised purity and reproducible, predictable
results. One of the biggest foibles of the Ayurvedic medicine has been variable
responses, either due to variations in sources of the herbs or due to differing
storage conditions. Also the lack of clinical documentation and studies on the
dose-effect relationship of a product have made doctors wary of prescribing
Ayurvedic medicines.
|| Vision ||
To be a Leading International Herbal
Healthcare Company,
Improving Quality of Life.
|| Mission ||
Provide Standardized and Researched Herbal
Healthcare Products and services for consumer well being.
|| Values ||
. Customer is the most important person in
their Business
. Best Quality product is the only way to survive in the market
. Provide opportunity for their people to realize their full potential
. Concern for safety of people and the environment.
. Win-win situation to be encouraged in all dealings
The
Meaning of Ayurveda
Traditional systems
of medicine like Ayurveda have become popular in recent years. This is part of
the renewed ethnic cultures the world over, in their lifestyles and religious
beliefs. Medicine may be seen as a living component of an unbroken tradition
stretching back to several centuries. In India and her neighbours like Nepal,
Sri Lanka, Bangladesh and Pakistan, such systems have long being in existence
and studies scientifically and codified, with written texts that have been
preserved through the ages. Passed on from one generation to another, they have
stood the test of time. Of the many systems Ayurveda is perhaps the best known
most widely prevalent.
These systems are unique in that they are deeply rooted in traditional cultures
and draw upon their wisdom, knowledge and experience. But at the same time,
because they emanate from man’s interaction with the environment or the
macrocosm, they are applicable universally. They may be termed as alternative
systems of medicine only in relation to modern Western medicine. Ayurveda and
other such systems are both supplementary and complementary to modern medicine
in helping to provide good health to humanity.
Despite the advances in modern medicine there are many drugs, which often cause
toxic side effects. Painkillers and palliative measures offer only temporary
relief. This has influenced the need for other kinds of treatment. A visible
shift is also evident today from the over specialization which characterizes
modern medical science to a more holistic viewpoint in the treatment of
diseases. Holistic medicine as in Ayurveda, deals with the body-mind-spirit
complex. More than the specific disease, it is the patient who is sought to be
treated.
Good health thus becomes a whole way of life, which may be achieved by adopting
certain general principles of behaviour and following certain regimens.
Diseases may not only be cured but in fact may be prevented by observing these
rules.
Ayurveda also draws upon other traditional systems of medicines like
naturopathy, Tibetan Buddhist medicine and Unani tibb (Graeco-Arabic medicine)
since in theory and practice there is a high degree of commonality among them.
Practitioners of one system freely use the medicinal products of the other, as
they are all products of nature.
The word Ayurveda is made up of two Sanskrit words ayur and veda meaning ‘life’
and ‘knowledge’ respectively. Taken together they mean the ‘science of life’;
in a more limited sense, the term is used to imply the science of medicine.
The origins of Ayurveda are shrouded in antiquity. Legend say that Brahma the
Creator, a part of the holy trinity of gods, first perceived it and taught it
to his son, Daksha Prajapati. Subsequently, Lord Dhanwantari, the god of
healing and the teacher of the medical sciences passed it on to the prominent
Hindu sages Atreya, Bharadvaja, Kashyapa, Sushruta, Parashara, and Charaka.
Sage Atreya’s disciple Agnivesha is said to have written the original Agnivesha
Sambita around 1000 BC which has come down to us in the form of Charaka
Sambita. This text is considered an authoritative pronouncement of Ayurvedic
doctrine. Its present form goes back to the seventh century BC. Sage Charaka
defines Ayurveda as ‘the science through which one can obtain the knowledge
about the useful and harmful types of life (bita and abita ayus), happy and
miserable types of life, things which are useful and harmful for such types of
life, the span of life as well as the very nature of life’. Ayurveda thus
emphasizes on not only leading a happy life from an individualistic point of
view but also aims to be beneficial to society as a whole.
Health, according to Ayurveda, is not merely freedom from disease. It is
essential that body, mind and soul are in a excellent state so that the
individual can perform his functions and fulfil his role in life which in Vedic
philosophy is called dharma; and ultimately work towards the final goal of
salvation or moksha with the help of wealth, economic means which artha
satisfying his legitimate desires of love and sex which is kama. The roots of
Indian Culture can be traced back to the Vedic period, from c. 5000 BC or
perhaps even earlier. All the four Vedas - Rig, Yajur, Sama, Atharva - contain
several references to the digestive system, metabolism, anatomy and
descriptions of diseases along with the bacteria that cause them and more
importantly, the concept of tridosha or the three doshas. The doshas, according
to the Vedas, are subtle elements in the human body responsible for all its
functions. According to the dictates of Ayurveda, illnesses occur due to an
imbalance in the equilibrium between the three doshas - vayu, pitta, kapha.
Roughly translated, vayu (also known as vata) is wind, pitta can be represented
by bile and kapha by phlegm.
In India a large section of the vast population depends on the indigenous
Ayurvedic tradition, which has deep cultural roots because of its easy
availability, accessibility and reliability. The carries of this tradition are
the millions of housewives brought up in this culture, the hundreds of
birth-attendance, bone-setters, village herbalists, those skilled in eye-care,
dental care are in the specialized treatment of mental diseases. Ayurveda is a
body of knowledge, which is extremely coherent and logical within itself yet
not restricted by any fixed dogma. Like life itself, it is universal and
dynamic.
Charak Panchkarma
Centre
Charak Clinic A charitable Ayurvedic
dispensary situated in the heart
of Mumbai city, (India) since the year 1947, recognized as Charak
Clinic, was started with a keen effort of the Shroff brothers,
Dr.S.N.Shroff and Mr. D.N.Shroff to treat poor and needy patients with
the aid of safe, effective and affordable Ayurvedic Medicines.
Today, CHARAK CLINIC is not only an Ayurvedic dispensary, but also an
Alternative Medical Center with different activities as follows:
1. It serves the poor people who are not in a position to afford to
undergo a regular and timely diagnosis of their disorders. Charak
offers a free consultation by the eminent, well trained and
experienced Physicians.
Thus, with the help of these qualified Ayurvedic Physicians, one can
avail of the benefits of "Health Forever Naturally"
2. Ayurvedic Panchkarma Centre to treat chronic cases with special
Ayurvedic treatment modalities like Vaman (Induced Emesis), Virechan
(Induced Purgation), Basti (Herbal Enemata), Shirodhara, Shirobasti,
Swedan (Steam bath, local fomentation), Hridbasti, Netra basti, Nasya
Nasal insufflation etc.
3. Charak Clinic also offers "Herbal Massage" for men and women.
One
can experience a soothing and tranquilizing effect of these Massages.
As each individual has a different constitution, a medical supervision
is conducted prior to stepping in for these herbal Massages.
Symptoms
|
|
CMT REPORT [Corruption, Money
laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the subject of any
formal or informal allegations, prosecutions or other official proceeding for
making any prohibited payments or other improper payments to government
officials for engaging in prohibited transactions or with designated parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation
with Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation
Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs.44.30 |
|
UK
Pound |
1 |
Rs.87.61 |
|
Euro |
1 |
Rs.57.61 |
SCORE &
RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
8 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
8 |
|
--LEVERAGE |
1~10 |
8 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
8 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
72 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit
history (10%) Market
trend (10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|